Xiao-hui Ling
Huizhou, 516001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Analysis of ultrastructural defects in sperm by transmission electron microscopy in asthenozoospermia patients: a study from multiple centers across China.
Journal: Biomarker research
Published: June 30, 2025
miR‑505 suppresses prostate cancer progression by targeting NRCAM.
Journal: Oncology reports
Published: February 17, 2019
[Corrigendum] miR‑505 suppresses prostate cancer progression by targeting NRCAM.
Journal: Oncology reports
Published: February 17, 2019
miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
Journal: Molecular medicine reports
Published: June 18, 2016
Correlation of oxidative stress with sperm DNA integrity and semen parameters in infertile men with varicocele
Journal: Zhonghua nan ke xue = National journal of andrology
Published: June 01, 2016
Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.
Journal: International journal of biological macromolecules
Published: February 11, 2015
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.
Journal: Oncology letters
Published: November 18, 2014
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: November 22, 2013
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Journal: International journal of cancer
Published: June 14, 2013
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Journal: Molecular biology reports
Published: April 15, 2013
Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
Journal: BMC genomics
Published: February 27, 2013
Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: September 28, 2012
Last Updated: 09/26/2026